PRESS RELEASE published on 07/17/2026 at 18:00, 2 months 4 days ago ABIVAX: Nombre d’actions composant le capital social et nombre total de droits de vote au 30.06.26 ABIVAX publie les nombres d'actions et de droits de vote au 30/06/26 conformément aux réglementations AMF. La société se concentre sur le développement de traitements pour les maladies inflammatoires Droits De Vote Actions Abivax Réglementation Traitements
BRIEF published on 07/06/2026 at 22:10, 2 months 15 days ago Abivax Completes its $920 Million Public Offering Biotechnology Actions Funding Abivax Public Offering
BRIEF published on 07/06/2026 at 22:10, 2 months 15 days ago Abivax Achève son Offre Publique de 920 Millions de Dollars Biotechnologie Actions Financement Abivax Offre Publique
BRIEF published on 07/06/2026 at 22:10, 2 months 15 days ago Abivax Secures $920 Million in Public Offering Biotechnology Abivax Ulcerative Colitis Public Offering American Depositary Shares
BRIEF published on 07/06/2026 at 22:10, 2 months 15 days ago Abivax lève 920 millions de dollars lors d'une offre publique Biotechnologie Abivax Rectocolite Hémorragique Offre Publique Actions De Dépôt Américaines
PRESS RELEASE published on 07/06/2026 at 22:05, 2 months 15 days ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars Abivax réalise son offre publique de 920 millions de dollars pour le développement de thérapies biotechnologiques. Les actions sont cotées sur Euronext Paris et le Nasdaq Biotechnologie Abivax Offre Publique Thérapies Cotées
PRESS RELEASE published on 07/06/2026 at 22:05, 2 months 15 days ago Abivax annonce la réalisation de son offre au public de 920 millions de dollars Abivax annonce la réalisation de son offre au public de 920 millions de dollars. La société de biotechnologie lève des fonds pour ses thérapies contre les maladies inflammatoires Biotechnologie Abivax Offre Publique Maladies Inflammatoires Millions De Dollars
PRESS RELEASE published on 07/06/2026 at 22:05, 2 months 15 days ago Abivax Announces Closing of $920 Million Public Offering Abivax closes $920 million public offering, strengthening financial position. Proceeds to support operations until Q4 2029. Leerink Partners, Morgan Stanley, Piper Sandler, Guggenheim Securities involved in the offering Financial Position Abivax Morgan Stanley Public Offering Leerink Partners
BRIEF published on 07/02/2026 at 08:05, 2 months 19 days ago Abivax successfully concludes an ADS offer Biotechnology Abivax Offer Ads Investments
BRIEF published on 07/02/2026 at 08:05, 2 months 19 days ago Abivax conclut une offre d'ADS avec succès Biotechnologie Abivax Investissements Ads Offre
Published on 09/21/2026 at 15:45, 8 hours 28 minutes ago Datavault AI and Cutting-Edge Sports Management Announce Dream Bowl XV at AT&T Stadium and Launch First-of-Its-Kind Bowl Combine
Published on 09/21/2026 at 14:20, 9 hours 53 minutes ago Doctor's Choice(R) Clinically-Proven Scrubs Launching on Amazon Canada
Published on 09/21/2026 at 14:05, 10 hours 8 minutes ago Winners of this Year's Semmelweis-Richter International Journalism Award Announced
Published on 09/21/2026 at 14:00, 10 hours 13 minutes ago Dateline Files Motion to Resume Operations at Colosseum
Published on 09/21/2026 at 22:05, 2 hours 8 minutes ago Abivax Presents Business Updates and First Half 2026 Financial Results
Published on 09/21/2026 at 22:05, 2 hours 8 minutes ago Abivax présente les dernières avancées de ses activités et ses résultats financiers du premier semestre 2026
Published on 09/21/2026 at 20:34, 3 hours 38 minutes ago BRANICKS Group AG: Regular interest payment on EUR 400 million bond to be made as scheduled – Completion of maturity extension imminent
Published on 09/21/2026 at 19:00, 5 hours 13 minutes ago PATRIMOINE ET COMMERCE: Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 14 septembre 2026 au 18 septembre 2026
Published on 09/21/2026 at 18:00, 6 hours 13 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 09/21/2026 at 18:19, 5 hours 54 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain du 14 au 18 septembre 2026
Published on 09/21/2026 at 18:19, 5 hours 54 minutes ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 6 hours 11 minutes ago Partnership agreement signed between Manitou Group and HD Construction Equipment
Published on 09/21/2026 at 17:46, 6 hours 27 minutes ago WEB SA - STATUTORY HALF-YEAR RESULTS AS OF 30/06/2026
Published on 09/21/2026 at 17:46, 6 hours 27 minutes ago WEB SA - RESULTATS SEMESTRIELS STATUTAIRES AU 30/06/2026
